• No results found

PhD School of Molecular Metabolism and Danish Cardiovascular Research Academy

N/A
N/A
Protected

Academic year: 2021

Share "PhD School of Molecular Metabolism and Danish Cardiovascular Research Academy"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

(1)

PhD School of Molecular Metabolism and

Danish Cardiovascular Research Academy

PhD Course on “Molecular Mechanisms in the Metabolic Syndrome” - 3 ECTS

Time: 29 October – 1 November 2007

Place: Trinity Hotel and Conference Center A/S, Fredericia, Denmark

Topics:

- Basic molecular and pathophysiological aspects of insulin resistance - Multiphase consequences of insulin resistance and hyperinsulinaemia - Biochemical role of obesity

- The basic biochemistry of the atheromatous vascular disease

- Development of and the disordered kinetics of the dislipidaemia in vascular disease - Pathophysiology of hypertension and its relationship to the development of the syndrome - Biochemical and metabolic impact of glucose intolerance

- The clinical and the therapeutic implications arising out of the above pretentions will be stressed throughout the course.

Prerequisites: PhD candidates in Diabetes, Endocrinology, Cardiology and Higher Physician training, as a postgraduate segment towards their PhD degree.

Registration: Registration form can be found at www.metabolism-phd.dk and must be forwarded to the Secretariat of the PhD School of Molecular Metabolism no later than 7 September 2007 (tine.christensen@ouh.regionsyddanmark.dk)

Price: 7,000 DKK. PhD and pre-graduate medical students free of charge.

(2)

PhD School of Molecular Metabolism and

Danish Cardiovascular Research Academy

PhD Course:

Molecular Mechanisms in the Metabolic Syndrome

29 October (Monday) – 1 November (Thursday) 2007

Programme

DAY 1: Monday 29 October 2007

9.00 – 9.30 a.m. Registration and refreshments

9.30 – 9.40 a.m. Welcome & Intro HBN

SESSION I THE METABOLIC SYNDROME

Chair person: Henning Beck-Nielsen

9.40 – 10.20 a.m. The Metabolic Syndrome (MS):

Definition, clinical features and metabolic “costs” in 2007.

HBN

10.20 – 10.30 a.m. Discussion

Workshop:

10.30 – 12.30 a.m. Insulin resistance – what is it and how do we measure it?

JEH/OHN

A. The “Clamp technique” (including indirect

calorimetry, glucose turnover measurements, glucose processing invivo and muscle biopsy procedure) (10.30-11.30 and 11.30-12.30)

B. Surrogate measurements: Fasting plasma insulin,

(3)

12.30 – 1.30 p.m. Lunch

1.30 – 2.10 p.m. The normal glucose and fat metabolism NF/JK

2.10 – 2.20 p.m. Discussion

2.20 – 3.00 p.m. Molecular/Biochemical basis of insulin resistance. KH

3.00 – 3.10 p.m. Discussion

3.10 – 3.50 p.m. Mitochondrial function and insulin resistance MM

3.50 – 4.00 p.m. Discussion

4.00 – 4.30 p.m. Coffee/tea break

SESSION II EPIDEMIOLOGY OF MS; GENOME AND MS;

THE LIVER AND MS; SKELETAL MUSCLE AND MS

Chair person: Kurt Højlund

4.30 – 5.10 p.m. The liver and its role in the metabolic syndrome OHN

5.10 – 5.20 p.m. Discussion

5.20 – 6.10 p.m. Non-alcoholic fatty liver (NAFL) and insulin

resistance

HYJ

6.10 – 6.20 p.m. Discussion

(4)

DAY 2: Tuesday 30 October 2007

Chair person: Bjørn Richelsen

8.30 – 9.10 a.m. The epidemiology of the metabolic syndrome KBJ

9.10 – 9.20 a.m. Discussion

9.20 – 10.00 a.m. The genome and the metabolic syndrome TH

10.00 -10.10 a.m. Discussion

10.10 – 10.40 a.m. Coffee/tea break

10.40 – 11.20 a.m. Obesity and its role in the development of the MS. BR

11.20 – 11.30 a.m. Discussion

11.30 – 12.10 The adipocytokines (Leptin, adiponectin, TNFalpha) BR

12.10 – 12.20 Discussion

12.20 – 1.30 p.m. Lunch

SESSION III THE ROLE OF EXERCISE

Chair person: Jørgen Wojtaszewski

1.30 – 2.10 p.m. The role of skeletal muscle in the metabolic syndrome KH

2.10 – 2.20 p.m. Discussion

2.20 – 3.00 p.m. The signalling cascade for energy supply in exercising skeletal muscle of normal and insulin resistant

subjects.

(5)

3.00 – 3.10 p.m. Discussion

3.10 – 3.50 p.m. Exercise as “medicine” FD

3.50 – 4.00 p.m. Discussion

4.00 – 4.30 p.m. Coffee/tea break

SESSION IV FFA AND PPARS

Chair person: Susanne Mandrup

4.30 – 5.10 p.m. I. The PPAR system in fat metabolism. SM

5.10 – 5.20 p.m. Discussion

5.20 – 6.00 p.m. II. The PPAR system – a clinicopathological

perspective.

HBN

6.00 – 6.10 p.m. Discussion

(6)

DAY 3: Wednesday 31 October 2007

SESSION V ENDOTHELIAL FUNCTION

Chair person: Christian Torp Pedersen

8.30 – 9.10 a.m. Lipoprotein lipase (LPL) and lipid turnover – the

importance of LPL to the metabolic syndrome and cardiovascular diseases

FLH

9.10 – 9.20 a.m. Discussion

9.20 – 10.00 a.m. Interleukin-6 – inflammation, insulin resistance and

exercise: its role in the metabolic syndrome

BK

10.00 -10.10 a.m. Discussion

10.10 – 10.40 a.m. Coffee/tea break

10.40 – 11.20 a.m. Endothelial function and the metabolic syndrome CRM

11.20 – 11.30 a.m. Discussion

11.30 – 12.10 Endothelial function and cardiovascular disease CTP

12.10 -12.20 Discussion

12.20 – 1.30 p.m. Lunch

SESSION VI DYSLIPIDAEMIA

Chair person: Børge Nordestgaard

1.30 – 2.10 p.m. I. Dyslipidaemia – lipid turnover and its implication

for insulin resistance.

BN

(7)

2.20 – 3.00 p.m. II. Dyslipidaemia – implications for the development of atherosis and vascular disease.

BN

3.00 – 3.10 p.m. Discussion

3.10 – 3.50 p.m. Metabolic syndrome in the cardiovascular clinic PH

3.50 – 4.00 p.m. Discussion

4.00 – 4.30 p.m. Coffee/tea break

4.30 – 5.10 p.m. Evidence based management of dyslipidaemia in the

metabolic syndrome: How relevant are targets to outcomes?

HSH

5.10 – 5.20 p.m. Discussion

5.20 – 6.00 p.m. The prenatal/intrauterine environment in the

development of the metabolic syndrome and arteriosclerosis

PP

6.10 – 6.20 p.m. Discussion

(8)

DAY 4: Thursday 1 November 2007

SESSION VII HYPERTENSION AND MS

Chair person: Henning Beck-Nielsen

8.30 – 9.10 a.m. Hypertension and the metabolic syndrome CB

9.10 – 9.20 a.m. Discussion

9.20 – 10.00 a.m. PCOS and the MS – insulin resistance and

dyslipidaemia

DG

10.00 – 10.10 a.m. Discussion

10.10 – 10.40 a.m. Coffee/tea break

10.45 – 12.15 Workshop/seminar

Newer techniques in defining the dysmetabolic signalling cascades in the metabolic syndrome: 1) Proteomics 2) Transcriptomics 3) Lipidomics 4) Bioinformatics ML QT JK SB

12.15 – 12.30 Questions to the entire course curriculum HBN

(9)

FACULTY Henning Beck-Nielsen (HBN)

Course leader

Professor of Medicine Dept. of Endocrinology Odense University Hospital DENMARK Henning.beck-nielsen@ouh.regionsyddanmark.dk Sten Christensen (SC) Course leader Professor Dept. of Pharmacology University of Copenhagen DENMARK Sten.christensen@farmakol.ku.dk

Christian Berne (CB) Professor

Endocrinology and Diabetes section The Uppsala Academic Hospital SWEDEN

Christian.berne@akademiska.se

Knut Borch-Johnsen (KBJ) Professor, Chief physician

Steno Diabetes Center Copenhagen

DENMARK

kbjo@steno.dk

Søren Brunak (SB) Professor

Biocentrum

Technical University of Denmark Kgs. Lyngby

DENMARK

brunak@cbs.dtu.dk

Flemming Dela (FD) Professor, DMSc

Dept. of Medical Physiology Panum Institute

University of Copenhagen DENMARK

Fdela@mfi.ku.dk

Nils Færgeman (NF) Associate Professor

Dept. of Biochemistry and Molecular Biology University of Southern Denmark

DENMARK

Nils.f@bmb.sdu.dk

Dorte Glintborg (DG) MD, PhD

(10)

Henrik Steen Hansen (HSH) Associate professor, MD, DMSc Dept. of Cardiology

Odense University Hospital DENMARK

Henrik.steen.hansen@ouh.regionsyddanmark.dk

Torben Hansen (TH) MD

Steno Diabetes Center Copenhagen

DENMARK

toha@steno.dk

Per Hildebrandt (PH) Head of department, Chief physician, DMSc

Clinical Research Unit, Dept. of Cardiology and Endocrinology E

Frederiksberg Hospital DENMARK

Per.hildebrandt@fh.hosp.dk

Jan Erik Henriksen (JEH) MD, PhD

Dept. of Endocrinology Odense University Hospital DENMARK

Jan.erik.henriksen@ouh.regionsyddanmark.dk

Finn Lund Henriksen (FLH) MD, PhD

Dept. of Cardiology

Odense University Hospital DENMARK

f.l.henriksen@dadlnet.dk

Ole Hother-Nielsen (OHN) DMSc

Dept. of Endocrinology Odense University Hospital DENMARK

Ole.hother-nielsen@ouh.regionsyddanmark.dk

Kurt Højlund (KH) MD, PhD

Dept. of Endocrinology Odense University Hospital DENMARK

k.hojlund@dadlnet.dk

Bente Klarlund (BK) Professor

Muscle Research Centre Rigshospitalet

Copenhagen DENMARK

(11)

Jens Knudsen (JK) Professor

Dept. of Biochemistry and Molecular Biology University of Southern Denmark

DENMARK

jkk@bmb.sdu.dk

Martin Larsen (ML) Research professor, PhD

Dept. of Biochemistry and Molecular Biology University of Southern Denmark

DENMARK

mrl@bmb.sdu.dk

Christian Rask Madsen (CRM) Research Fellow

Harvard Medical School Joslin Diabetes Center Boston

USA

Christian.rask-madsen@joslin.harvard.edu

Susanne Mandrup (SM) Associate professor

Dept. of Biochemistry and Molecular Biology University of Southern Denmark, Odense DENMARK

s.mandrup@bmb.sdu.dk

Martin Mogensen (MM) MSc, PhD student

Institute of Sports Science and Biomechanics University of Southern Denmark

DENMARK

mmogensen@health.sdu.dk

Børge Nordestgaard (BN) Professor

Department of Clinical Biochemistry Herlev County Hospital

DENMARK

brno@herlevhosp.kbhamt.dk

Christian Torp Pedersen (CTP) Professor

Clinic of Cardiology Y Bispebjerg Hospital DENMARK

ctp@heart.dk

Pernille Poulsen (PP) Post.doc.

Steno Diabetes Center, Gentofte DENMARK

(12)

Bjørn Richelsen (BR) Professor

Dept. of Medical Endocrinology Aarhus University Hospital DENMARK

Bjoern.richelsen@as.aaa.dk

Qihua Tan (QT) Assistant professor

Human MicroArray Center Odense University Hospital DENMARK

Qihua.tan@ouh.regionsyddanmark.dk

Jørgen Wojtaszewski (JW) Associate professor

August Krogh Institute University of Copenhagen DENMARK

jwojtaszewski@aki.ku.dk

Hannelei Yki-Järvinen (HYJ) Professor

Department of Medicine University of Helsinki FINLAND

ykijarvi@cc.helsinki.fi

Course secretariat:

PhD School of Molecular Metabolism Research secretary Tine Christensen Odense University Hospital

Dept. of Endocrinology Kloevervaenget 6, 4. 5000 Odense C Denmark Tel. +45 6541 1769 Fax +45 6591 9653 E-mail: tine.christensen@ouh.regionsyddanmark.dk

Web site: www.metabolism-phd.dk/optcour.html - (B2)

Place: Trinity Hotel and Conference A/S, Gl. Færgevej 30, Snoghøj, Fredericia, Denmark

References

Related documents

Furthermore, as revealed by qualitative analysis, the correlation between the methylation status of the MGMT promoter and the relative MGMT expression level (either positive

However, from the case studies, we have learned that a more declarative way to specify the condition when the corresponding context is active is heavily used in the

Component-and-Connector View Development View Physical View Process View Security Performance Availability Legend: C o n cer n s Replication Manager Module Cryptograph Manager

In the recursive residuals approach [Brown, Durbin and Evans (1975), Hawkins (1987), Quesenberry (1991, 1995), Del Castillo and Montgomery (1994), Koning and Does (1999), Koning

Metabolite AutoPlotter includes different features to overcome this limitation, e.g., by overlaying the individ- ual data points or using violin plots to better represent

For retail and consumer goods companies, future growth in emerging markets will be heavily impacted by e-commerce. Understanding how politics play into this – and keeping a

In this study, an instructional design framework was proposed to enable students to practice both active and reflective learning processes through a flipped